Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions |
umls-concept:C0015219,
umls-concept:C0021747,
umls-concept:C0030685,
umls-concept:C0205210,
umls-concept:C0205359,
umls-concept:C0391871,
umls-concept:C0680255,
umls-concept:C0681850,
umls-concept:C1283071,
umls-concept:C1550501,
umls-concept:C1706203,
umls-concept:C1963578,
umls-concept:C2349001,
umls-concept:C2697811,
umls-concept:C2698872
|
pubmed:issue |
1
|
pubmed:dateCreated |
1991-5-16
|
pubmed:abstractText |
In order to establish a correlation with disease progression we prospectively evaluated ten clinical and immunologic parameters in 102 consecutive HIV-positive subjects. The eight immunologic variables were: in vitro spontaneous interferon release by peripheral blood monocytic cells, alpha- and gamma-interferon production induced by Newcastle Disease Virus and PHA, Multitest Mérieux score, PHA- and CON-A-induced lymphocyte transformation, absolute number of CD4+ cells and CD4/CD8 ratio, respectively. The two baseline clinical variables were risk factor and disease presentation. Generalized Wilcoxon analysis indicated a significant correlation of one clinical (disease presentation at entry) and three immunologic variables (spontaneous interferon release, CD4+ cell number, Multitest Mérieux) with disease progression. Baseline spontaneous release of alpha, acid-labile interferon showed the best correlation with disease progression, and appeared to be significantly associated with CD4+ cell loss. Spontaneous release of acid-labile alpha interferon by mononuclear cells in vitro could be highly predictive of disease evolution in HIV-Ab positive, AIDS-free subjects.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0300-8126
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
19
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
7-12
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:2013514-Evaluation Studies as Topic,
pubmed-meshheading:2013514-HIV Seropositivity,
pubmed-meshheading:2013514-Humans,
pubmed-meshheading:2013514-Interferon Type I,
pubmed-meshheading:2013514-Leukocytes, Mononuclear,
pubmed-meshheading:2013514-Lymphocyte Activation,
pubmed-meshheading:2013514-Prospective Studies,
pubmed-meshheading:2013514-Risk Factors
|
pubmed:articleTitle |
Spontaneous release of interferon as a predictor of clinical evolution in HIV-positive subjects.
|
pubmed:affiliation |
Istituto di Malattie Infettive, Università di Torino, Italy.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|